Literature DB >> 7769533

The quantitative determination of Photofrin and Polyhaematoporphyrin in plasma: pitfalls and inaccuracies.

D I Vernon1, J A Holroyd, S M Stribbling, S B Brown.   

Abstract

An accurate and relatively rapid fluorometric assay for Photofrin, or our own preparation Polyhaematoporphyrin (PHP), in plasma has been developed. This method takes into account the significant proportion of hydrolysis-resistant material now known to be present in these sensitizers, which has undoubtedly led to the inaccurate assessment of these drugs and other preparations of haematoporphyrin derivative (HPD) in numerous studies. The method was devised to allow for incomplete hydrolysis by calibration with plasma samples to which known amounts of photosensitizer were added in vitro. It was then compared with an "absolute" method in which plasma from animals that had received 14C-labelled drug was subjected to radioactivity assay. The two approaches gave almost identical results. The calibration method is applicable to the determination of any HPD-derived drug from patient or animal studies. As an example of its use in the present study, it was applied to the determination of the pharmacokinetics of PHP in the rat.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7769533     DOI: 10.1016/1011-1344(94)07079-4

Source DB:  PubMed          Journal:  J Photochem Photobiol B        ISSN: 1011-1344            Impact factor:   6.252


  4 in total

1.  Susceptibility of Candida species to photodynamic effects of photofrin.

Authors:  Joseph M Bliss; Chad E Bigelow; Thomas H Foster; Constantine G Haidaris
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

2.  Lack of effect of sex and disease state on the pharmacokinetics of porfimer sodium.

Authors:  Jean-Marie Houle; Nadine Clervoix; Stacey Bain; Jean Spénard
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

3.  The sensitivity of normal brain and intracranially implanted VX2 tumour to interstitial photodynamic therapy.

Authors:  L Lilge; M C Olivo; S W Schatz; J A MaGuire; M S Patterson; B C Wilson
Journal:  Br J Cancer       Date:  1996-02       Impact factor: 7.640

4.  Photodynamic therapy effect of m-THPC (Foscan) in vivo: correlation with pharmacokinetics.

Authors:  H J Jones; D I Vernon; S B Brown
Journal:  Br J Cancer       Date:  2003-07-21       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.